Citation Information :
Mohapatra P, Kumar A, Singh RK, Gupta R, Hussain M, Singh S, Kumar P. The Effect of Sepsis and Septic Shock on the Viscoelastic Properties of Clot Quality and Mass Using Thromboelastometry: A Prospective Observational Study. Indian J Crit Care Med 2023; 27 (9):625-634.
Background: Sepsis is associated with wide variable coagulation abnormalities. Thromboelastography (TEG) effectively measures the viscoelstic properties of the clots. This study aims to illustrate the viscoelastic properties of clot quality and mass in sepsis and septic shock patients using TEG, as an effective tool over standard coagulation tests.
Materials and methods: A single-center, prospective observational study was conducted. 50 patients each meeting the criteria for sepsis and septic shock, and a healthy group of 30 patients were included in the study. Blood samples were obtained and analyzed for standard coagulation tests, platelet count, fibrinogen, and TEG study.
Results: A total of 130 patients were included. Septic shock patients had a higher sequential (sepsis-related) organ failure score. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) were increased significantly as compared to the sepsis and control groups. TEG markers such as alpha angle, and maximum amplitude (MA) were significantly prolonged while reaction time (R time), was significantly shortened in the sepsis group as compared to the healthy group, suggestive of a hypercoagulable state in sepsis patients. While in septic shock patients, MA and Lysis Index 30 (LY 30) were significantly prolonged and, R time was significantly shortened compared to all other groups. Even though LY30 in sepsis patients was found to be within the normal range (p < 0.001), 18% of patients had prolonged LY30 indicating a hypercoagulable state with impaired fibrinolysis.
Conclusion: Thromboelastography, as a point-of-care test combined with conventional coagulation tests can provide additional, clinically relevant information on coagulopathy, and outcome, and thus help guide treatment modality in sepsis and septic shock-induced coagulopathy.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017;43(3):304–377. DOI: https://doi.org/10.1007/s00134-017-4683-6.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–810. DOI: 10.1001/jama.2016.0287.
Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):775–787. DOI: 10.1001/jama.2016.0289.
Dempfle CE. Coagulopathy of sepsis. Thromb Haemost 2004;91(2):213–224. DOI: 10.1160/TH03-03-0182.
Simmons J, Pittet F. The coagulopathy of acute sepsis. Current opinion in anaesthesiology 2015;28(2):227–236. DOI: https://doi.org/10.1097/ACO.0000000000000163
Ostrowski SR, Windeløv NA, Ibsen M, Haase N, Perner A, Johansson PI. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: A prospective study. J Crit Care 2013;28(3):317 e1–e11. DOI: 10.1016/j.jcrc.2012.09.003.
Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006;135(2):220–227. DOI: 10.1111/j.1365-2141.2006.06281.x.
Shaydakov ME, Sigmon DF, Blebea J. Thromboelastography. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
Thakur M, Ahmed AB. A review of thromboelastography. Int J Periop Ultrasound Appl Technol 2012;1(1):25–29. DOI: 10.5005/jp-journals-10027-1006.
Chris Nickson, “Thromboelastogram (TEG),” In: LITFL - Life in the fast lane, 2023; Available from: https://litfl.com/thromboelastogram-teg/.
Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001;12(5):327–337. DOI: https://doi.org/10.1097/00001721-200107000-00001.
Whiting D, DiNardo JA. TEG and ROTEM: Technology and clinical applications. Am J Hematol 2014;89(2):228–232. DOI: https://doi.org/10.1002/ajh.23599.
Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren [Blood clotting studies with Thrombus stressography; A new Investigation procedure]. Klin Wochenschr 1948;26(37–38):577–583. DOI: 10.1007/BF01697545.
Zhou W, Zhou W, Bai J, Ma S, Liu Q, Ma X. TEG in the monitoring of coagulation changes in patients with sepsis and the clinical significance. Exp Ther Med 2019;17(5):3373–3382. DOI: https://doi.org/10.3892/etm.2019.7342.
Zhao H, Cai X, Liu N, Zhang Z. Thromboelastography as a tool for monitoring blood coagulation dysfunction after adequate fluid resuscitation can predict poor outcomes in patients with septic shock. J Chin Med Assoc 2020;83(7):674–677. DOI: 10.1097/JCMA.0000000000000345.
Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers 2016;2:16045. DOI: 10.1038/nrdp.2016.45.
Vincent JL. How I treat septic shock. Intensive Care Med 2018;44(12):2242–2244. DOI: https://doi.org/10.1007/s00134-018-5401-8.
Iba T, Levy JH, Raj A, Warkentin TE. Advance in the Management of Sepsis-Induced coagulopathy and disseminated intravascular coagulation. J Clin Med 2019;8(5):728. DOI: https://doi.org/10.3390/jcm8050728.
Davies GR, Lawrence M, Pillai S, Mills GM, Aubrey R, Thomas D, et al. The effect of sepsis and septic shock on the viscoelastic properties of clot quality and mass using rotational thromboelastometry: A prospective observational study. J Crit Care 2018;44:7–11. DOI: 10.1016/j.jcrc.2017.09.183.
Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, et al. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: Comparison with severe sepsis and septic shock. Intensive Care Med 2001;27(12):1853–1859. DOI: https://doi.org/10.1007/s00134-001-1139-8.
Verma A, Baronia AK, Singh RK, Muzaffar SN, Azim A. Thromboelastography for evaluation of coagulopathy in nonbleeding patients with sepsis at intensive care unit admission. Indian J Crit Care Med 2017;21(5):268–273. DOI: 10.4103/ijccm.IJCCM_72_17.
Levi M, van der Poll T. Coagulation and sepsis. Thromb Res 2017;149:38–44. DOI: 10.1016/j.thromres.2016.11.007.
Govil D, Pal D. Point-of-care testing of coagulation in intensive care unit: Role of thromboelastography. Indian J Crit Care Med 2019;23(Suppl 3):S202–S206. DOI: 10.5005/jp-journals-10071-23253.
Kim SM, Kim SI, Yu G, Kim JS, Hong SI, Chae B, et al. Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time. Sci Rep 2021;11(1):11833. DOI: 10.1038/s41598-021-91221-3.
Müller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014;18(1):R30. DOI: 10.1186/cc13721.
Solomon C, Schöchl H, Ranucci M, Schlimp CJ. Can the viscoelastic parameter α-angle distinguish fibrinogen from platelet deficiency and guide fibrinogen supplementation? Anesth Analg 2015;121(2):289–301. DOI: 10.1213/ANE.0000000000000738.
Harr JN, Moore EE, Ghasabyan A, Chin TL, Sauaia A, Banerjee A, et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 2013;39(1):45–49. DOI: 10.1097/SHK.0b013e3182787122.
Sivula M, Pettilä V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009;20(6):419–426. DOI: 10.1097/MBC.0b013e32832a76e1.